Anti-CD25 antibody-drug conjugates: improving the delivery of death to lymphoma cells?

被引：0

作者：

Schmitz, Norbert ^{[1
]}

Lenz, Georg ^{[1
]}

机构：

[1] Univ Hosp Munster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany

来源：

LANCET HAEMATOLOGY | 2021年 / 8卷 / 06期

关键词：

DENILEUKIN DIFTITOX; TRIAL;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E387 / E389

页数：3

共 8 条

[1] Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma [J].

Connors, J. M. ;

Jurczak, W. ;

Straus, D. J. ;

Ansell, S. M. ;

Kim, W. S. ;

Gallamini, A. ;

Younes, A. ;

Alekseev, S. ;

Illes, A. ;

Picardi, M. ;

Lech-Maranda, E. ;

Oki, Y. ;

Feldman, T. ;

Smolewski, P. ;

Savage, K. J. ;

Bartlett, N. L. ;

Walewski, J. ;

Chen, R. ;

Ramchandren, R. ;

Zinzani, P. L. ;

Cunningham, D. ;

Rosta, A. ;

Josephson, N. C. ;

Song, E. ;

Sachs, J. ;

Liu, R. ;

Jolin, H. A. ;

Huebner, D. ;

Radford, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (04) :331-344

[2] Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma [J].

Dang, Nam H. ;

Fayad, Luis ;

McLaughlin, Peter ;

Romaguara, Jorge E. ;

Hagemeister, Fredrick ;

Goy, Andre ;

Neelapu, Sattva ;

Samaniego, Felipe ;

Walker, Pamela L. ;

Wang, Michael ;

Rodriguez, Maria A. ;

Tong, Ann T. ;

Pro, Barbara .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (04) :502-505

[3]

Hamadani M, 2021, LANCET HAEMATOL, V8, pE433, DOI 10.1016/S2352-3026(21)00103-4

[4] Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma [J].

Hamadani, Mehdi ;

Radford, John ;

Carlo-Stella, Carmelo ;

Caimi, Paolo F. ;

Reid, Erin ;

O'Connor, Owen A. ;

Feingold, Jay M. ;

Ardeshna, Kirit M. ;

Townsend, William ;

Solh, Melhem ;

Heffner, Leonard T. ;

Ungar, David ;

Wang, Luqiang ;

Boni, Joseph ;

Havenith, Karin ;

Qin, Yajuan ;

Kahl, Brad S. .

BLOOD, 2021, 137 (19) :2634-2645

[5] Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma [J].

Prince, H. Miles ;

Duvic, Madeleine ;

Martin, Ann ;

Sterry, Wolfram ;

Assaf, Chalid ;

Sun, Yijun ;

Straus, David ;

Acosta, Mark ;

Negro-Vilar, Andres .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) :1870-1877

[6] How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future [J].

Schmitz, Norbert ;

de Leval, Laurence .

BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (06) :851-866

[7] Diffuse Large B-Cell Lymphoma [J].

Sehn, Laurie H. ;

Salles, Gilles .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09) :842-858

[8] Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J].

Sehn, Laurie H. ;

Herrera, Alex F. ;

Flowers, Christopher R. ;

Kamdar, Manali K. ;

McMillan, Andrew ;

Hertzberg, Mark ;

Assouline, Sarit ;

Kim, Tae Min ;

Kim, Won Seog ;

Ozcan, Muhit ;

Hirata, Jamie ;

Penuel, Elicia ;

Paulson, Joseph N. ;

Cheng, Ji ;

Ku, Grace ;

Matasar, Matthew J. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) :155-+

← 1 →